OP 1.8 – 00204 Romidepsin in combination with the BCL-2 antagonist venetoclax synergistically reduce the size of the HIV reservoir
Y. Kim,
C. Tumpach,
J. Ong,
A. Solomon,
J. McMahon,
P. Arandjelovic,
M. Pelligrini,
M. Roche,
S. Lewin
Affiliations
Y. Kim
The University of Melbourne At The Peter Doherty Institute of Infection And Immunity, Melbourne, Australia
C. Tumpach
The University of Melbourne At The Peter Doherty Institute of Infection And Immunity, Melbourne, Australia
J. Ong
The University of Melbourne At The Peter Doherty Institute of Infection And Immunity, Melbourne, Australia
A. Solomon
The University of Melbourne At The Peter Doherty Institute of Infection And Immunity, Melbourne, Australia
J. McMahon
The Alfred Hospital And Monash University, Department of Infectious Disease, Melbourne, Australia
P. Arandjelovic
The Walter and Eliza Hall Institute of Medial Research, Melbourne, Australia
M. Pelligrini
The Walter and Eliza Hall Institute of Medial Research, Melbourne, Australia
M. Roche
The University of Melbourne At The Peter Doherty Institute of Infection And Immunity, Melbourne, Australia
S. Lewin
The University of Melbourne At The Peter Doherty Institute of Infection And Immunity, Melbourne, Australia; The Alfred Hospital And Monash University, Department of Infectious Disease, Melbourne, Australia
